Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States
Arthritis Care & Research · 2026-02 · 78 (2) · 188-196
DOI: 10.1002/acr.25609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 27.11.2025. Verfasst von Elizabeth Matz und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California at Los Angeles. Hauptthemen laut MEDLINE: Dermatomyositis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
We evaluated trends in dermatopolymyositis (DPM) mortality relative to all‐cause mortality in the United States from 1999 to 2022.
Methods
We used the Centers for Disease Control and Prevention's databases (Multiple Causes of Death for 1999–2020 and Provisional Mortality Statistics for 2021 and 2022) to obtain death counts for DPM and non‐DPM (all causes other than DPM). We calculated age‐standardized mortality rates (ASMRs) for both groups and computed the ratio of DPM‐ASMR to non–DPM‐ASMR for each of the 24 years. We performed joinpoint regression analysis to estimate annual percent change (APC) in DPM‐ASMRs and non–DPM‐ASMRs and in the DPM‐ASMR to non–DPM‐ASMR ratios overall and by sex, age, and race and ethnicity.
Results
There were 12,882 DPM and 63,549,485 non‐DPM deaths during 1999–2022. Mortality decreased at a higher APC (−3.8% [95% confidence interval (CI) −4.3% to −3.4%]) for DPM than for non‐DPM (−1.2% [95% CI −1.5% to −0.9%]) until the start of the COVID‐19 pandemic, when it increased for both at similar APCs. Consequently, the ratios of DPM‐ASMRs to non–DPM‐ASMRs decreased over these 24 years in all subgroups. The DPM‐ASMR to non–DPM‐ASMR ratios were higher in females than males and in younger individuals (≤64 years) than those aged ≥65 years. The odds of premature death were higher for DPM than for non‐DPM. Individuals of non‐Hispanic Black, Hispanic, and non‐Hispanic other race and ethnicity had higher DPM‐ASMR to non–DPM‐ASMR ratios than White individuals.
Conclusion
DPM mortality decreased at a higher rate than all‐cause mortality until the pandemic, when it proportionately increased for both DPM and all causes. Females, younger individuals, and individuals of Black, Hispanic, and non‐Hispanic other race and ethnicity had higher DPM mortality relative to all‐cause mortality. Findings highlight the need for improved screening, earlier intervention, and targeted efforts to address racial and ethnic disparities in DPM outcomes. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of California at Los Angeles.
ORCID-Profile: Ram R Singh
Zitieren
APA
Matz, E., & Singh, R. R. (2026). Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States. Arthritis Care & Research, 78(2), 188-196. https://doi.org/10.1002/acr.25609
Vancouver
Matz E, Singh RR. Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States. Arthritis Care & Research. 2026;78(2):188-196. doi:10.1002/acr.25609
BibTeX
@article{Matz2026,
author = {Matz, Elizabeth and Singh, Ram R},
title = {Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States},
journal = {Arthritis Care & Research},
year = {2026},
volume = {78},
number = {2},
pages = {188--196},
doi = {10.1002/acr.25609}
}
EUVIMED